These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37833493)

  • 1. Pharmacokinetics, Mass Balance and Metabolism of [
    Yuan JJ; Bian YC; Ma S; Chen W; Zhang FY; Zhang H; Miao LY
    Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):723-731. PubMed ID: 37833493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I clinical trial evaluating the safety, tolerance, pharmacokinetics and pharmacodynamics of HSK21542 injection in healthy volunteers.
    Shao R; Wang HY; Ruan ZR; Jiang B; Yang DD; Hu Y; Xu YC; Yang JT; Gao W; Zhao WY; Yan M; Lou H
    Basic Clin Pharmacol Toxicol; 2024 Dec; 135(6):743-754. PubMed ID: 39397291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Pharmacokinetics and Mass Balance of a Single Oral Dose of Trofinetide in Healthy Male Subjects.
    Darwish M; Nunez R; Youakim JM; Robertson P
    Clin Drug Investig; 2024 Jan; 44(1):21-33. PubMed ID: 38017349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [
    Guo F; Liu B; Li X; Wang H; Zhu X; Su Y; He C; Zhu M; Ding J; Xu Y; Zhao X; Wang Y; Shan R; Zhu J; Xie J; Ge Q; Fan L; Ding Y; Xie Y; Zhang C; Li H; Wang H; Zhou H
    Cancer Chemother Pharmacol; 2023 Feb; 91(2):143-156. PubMed ID: 36572783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass balance, metabolic disposition, and pharmacokinetics of [
    Zhou S; Liu W; Zhou C; Zhang L; Xie L; Xu Z; Wang L; Zhao Y; Guo L; Chen J; Ding L; Mao L; Tao Y; Zhang C; Ding S; Shao F
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):719-730. PubMed ID: 33044566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers.
    Reif S; Schultze-Mosgau MH; Engelen A; Piel I; Denner K; Roffel A; Tiessen R; Klein S; Francke K; Rottmann A
    Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):71-85. PubMed ID: 38044419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, Mass Balance, and Biotransformation of [
    Ni S; Ma S; Yu Y; Yu Z; Zhu Y; Sun X; Li L; Sun C; Wang H; Peng P; Gu Z; Zhang H; Wu F; Miao L; Fan J
    Drugs R D; 2024 Sep; 24(3):465-476. PubMed ID: 39231890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects.
    Acharya M; Gonzalez M; Mannens G; De Vries R; Lopez C; Griffin T; Tran N
    Xenobiotica; 2013 Apr; 43(4):379-89. PubMed ID: 23020788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, disposition, and metabolism of [14C]-nebicapone in humans.
    Wright LC; Maia J; Loureiro AI; Almeida L; Soares-Da-Silva P
    Drug Metab Lett; 2010 Aug; 4(3):149-62. PubMed ID: 20642448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, metabolism, excretion, and safety of [
    Zhou C; Xie L; Liu W; Zhang L; Zhou S; Wang L; Chen J; Li H; Zhao Y; Zhu B; Ding S; Zhang C; Shao F
    Ann Transl Med; 2021 May; 9(10):867. PubMed ID: 34164501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of absorption, distribution, metabolism, and excretion of [
    Liao M; Watkins S; Nash E; Isaacson J; Etter J; Beltman J; Fan R; Shen L; Mutlib A; Kemeny V; Pápai Z; van Tilburg P; Xiao JJ
    Invest New Drugs; 2020 Jun; 38(3):765-775. PubMed ID: 31250355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolite profiles and mass balance of fuzuloparib, a novel poly (ADP-ribose) polymerase inhibitor, in subjects with advanced solid cancers.
    Bian Y; Meng J; Ma S; Li G; Wang Y; Li S; Liu L; Huang C; Zhang H; Zhong D; Miao L
    Br J Clin Pharmacol; 2022 Jul; 88(7):3307-3320. PubMed ID: 35112382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and excretion of
    van Andel L; Fudio S; Rosing H; Munt S; Miguel-Lillo B; González I; Tibben MM; de Vries N; de Vries Schultink AHM; Schellens JHM; Beijnen JH
    Invest New Drugs; 2017 Oct; 35(5):589-598. PubMed ID: 28111728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase I, Open-Label, Mass Balance Study of [
    Cheng Y; Wang X; Liu L; Silva J; Thomas M; Li Y
    Eur J Drug Metab Pharmacokinet; 2024 May; 49(3):355-365. PubMed ID: 38521893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch.
    Wang X; Gou X; Yu X; Bai D; Tan B; Cao P; Qian M; Zheng X; Wang H; Tang P; Zhang C; Ye F; Ni J
    Front Pharmacol; 2021; 12():773204. PubMed ID: 34867403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects.
    Abel S; Russell D; Whitlock LA; Ridgway CE; Nedderman AN; Walker DK
    Br J Clin Pharmacol; 2008 Apr; 65 Suppl 1(Suppl 1):60-7. PubMed ID: 18333867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, mass balance, and metabolism of [
    Ma S; Wang X; Yan S; Miao L; Wan X; Ding D; Yu D; Diao X; Wang X; Zhang H
    Cancer Chemother Pharmacol; 2024 Nov; 94(5):647-657. PubMed ID: 38507062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass balance and pharmacokinetics of an oral dose of
    Dai X; Karol MD; Hitron M; Hard ML; Blanchard JE; Eraut NCJE; Rich N; Gufford BT
    Pharmacol Res Perspect; 2021 Feb; 9(1):e00722. PubMed ID: 33576192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass balance, routes of excretion, and pharmacokinetics of investigational oral [
    Zhou X; Pusalkar S; Chowdhury SK; Searle S; Li Y; Ullmann CD; Venkatakrishnan K
    Invest New Drugs; 2019 Aug; 37(4):666-673. PubMed ID: 30397836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose study.
    Pan M; Wang G; Zhou L; Xu Y; Yao L; Wu C; Mei C; Zhao Z; Sun D; Guan T; Chen Q; Shi M; Xu H; Zeng W; Li F; Yan R; Liu BC
    Front Pharmacol; 2023; 14():1203642. PubMed ID: 37876731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.